StonvexLoading…
StonvexStonvexStonvexCore line items from UNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.08B | $12.89B | $12.39B | $11.98B |
Operating Income | $933.50M | $2.25B | $1.64B | $1.75B |
Net Income | $738.50M | $1.78B | $1.28B | $1.41B |
EPS (Diluted) | $4.27 | $9.46 | $6.50 | $6.96 |
Total Assets | $63.52B | $61.96B | $63.26B | $61.15B |
Total Liabilities | $52.40B | $51.00B | $53.60B | $52.41B |
Cash & Equivalents | $158.20M | $162.80M | $146.00M | $119.20M |
Free Cash Flow OCF − CapEx | $555.40M | $1.39B | $1.07B | $1.32B |
Shares Outstanding | 172.92M | 188.07M | 197.60M | 202.11M |